The significant effect of HLA-DRB1 matching on long-term kidney graft outcome

Transplantation. 1993 Dec;56(6):1368-71. doi: 10.1097/00007890-199312000-00017.

Abstract

Serotyping and genotyping (polymerase chain reaction with sequence-specific oligonucleotide probes method) were conducted on 520 unrelated individuals to determine the linkage disequilibrium of HLA-B and HLA-DRB1. Analyses of 511 kidney transplants (300 related and 211 cadaver recipients) were carried out at 4 transplant centers using the linkage disequilibrium of HLA-B and HLA-DRB1 established previously. All transplant recipients received CsA immunosuppression and were transplanted from June 1983 to December 1991. There were 51 significant linkages formed between HLA-B and HLA-DRB1 alleles (P < 0.05). DRB1-compatible transplants experienced a comparable 5-year graft success rate of 94% as did the HLA-identical recipients with a 100% 5-year success rate. However DRB1-incompatible recipients displayed a significantly reduced 5-year graft survival rate of 73% (73% vs. 94% P < 0.01). The 5-year graft survival rate of HLA-DR-incompatible recipients of 71% was compatible to the 73% for HLA-DRB1-incompatible recipients. No variation of rejection rate for DRB1-compatible grafts was seen in any of the 4 transplant centers. The results also indicated that HLA-DRB1 compatibility was essential for optimal success rate, regardless of HLA class I mismatches. The overall conclusion was that matching for HLA-DR was important to achieve optimal kidney graft survival on the molecular level but not on the serotyping level.

MeSH terms

  • Alleles
  • Genotype
  • Graft Rejection / genetics
  • Graft Rejection / immunology
  • Graft Survival
  • HLA-B Antigens / genetics
  • HLA-DR Antigens* / genetics
  • HLA-DRB1 Chains
  • Histocompatibility Antigens Class II* / genetics
  • Histocompatibility Testing
  • Humans
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / immunology*
  • Linkage Disequilibrium
  • Polymerase Chain Reaction
  • Prognosis
  • Time Factors

Substances

  • HLA-B Antigens
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • Histocompatibility Antigens Class II